Crossmark

Serum (1→3)-β-D-glucan and galactomannan levels in patients with cystic fibrosis: a retrospective cohort study

Crossref DOI link: https://doi.org/10.1186/s12890-018-0614-8

Published Online: 2018-03-27

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Träger, Johannes

Melichar, Volker Otto

Meyer, Renate

Rauh, Manfred

Bogdan, Christian

Held, Jürgen http://orcid.org/0000-0003-1130-9727
License Information

Text and Data Mining valid from 2018-03-27
More Information

Article History

Received: 19 December 2017

Accepted: 13 March 2018

First Online: 27 March 2018

Ethics approval and consent to participate

: The study protocol was approved by the ethics committee of the Medical Faculty of the Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Germany (application number 7-17B). The need for informed consent was waived.

: Not applicable.

: JH received royalties for lectures from MSD as well as lecture royalties and a research grant from Pfizer. The remaining authors declare no conflict of interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.